Center for Scientific Review; Amended Notice of Meeting

---
identifier: "/us/fr/2025-19026"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Center for Scientific Review; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2025-19026"
section_name: "Center for Scientific Review; Amended Notice of Meeting"
positive_law: false
currency: "2025-09-30"
last_updated: "2025-09-30"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2025-19026"
document_type: "notice"
publication_date: "2025-09-30"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "90 FR 46902"
fr_volume: 90
---


#  Center for Scientific Review; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, RFA-AI-24-080 Broad Spectrum Products Against Multiple Neurotoxin Botulinum Serotypes (R61/R33 Clinical Trial Not Allowed). November 14, 2025, 10:00 a.m. to November 14, 2025, 05:00 p.m., National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the *Federal Register* on September 23, 2025, 90 FR 45775, Doc No. 2025-18347

This meeting is being amended to change the date from November 14, 2025, to December 2, 2025. The meeting is closed to the public.

Dated: September 26, 2025.

Denise M. Santeufemio,

Program Analyst, Office of Federal Advisory Committee Policy.